Neurological disease in the time of COVID-19
A case series
Abstract
Introduction: We described the neurological complications of patients with SARS-CoV-2 infection and reviewed literature based on the findings.
Patients and methods: We conducted a retrospective, descriptive study of consecutive patients admitted to the neurology service from August 1 to December 31, 2020.
Results: We included 30 patients, 16 were men (53%), and mean age 65 ± 17,3. Overall, 16/30 (53%) patients developed neurologic symptoms prior to traditional viral symptoms associated with COVID-19. The neurological conditions recorded were stroke 43% (13), seizures 10% (3), posterior reversible encephalopathy syndrome 10% (3), encephalopathy 7% (2), brief psychotic disorder 7% (2), myelopathy 3% (1), Guillain-Barré syndrome 3% (1), headache 3% (1), vasculitis 3% (1), intracerebral hemorrhage 3% (1), myasthenic crisis 3% (1) and optic neuritis 3% (1).
Conclusions: The neurological compromise of patients with SARS-CoV-2 is diverse and may be the first symptom even before the respiratory illness onset.
Metrics
Copyright (c) 2022 J. P. Garzón-Hernández, M. A. Buitrago-Gómez, S. A. Andrade-Rondón, Y. Álvarez-Pabón, J. A. Castellanos-Prada, D. M. Pinzón-Rincón, R. F. Trillos-Leal, L. A. Mora-Mora, L. C. Rueda-Guzmán, A. Reyes-Lobo, F. A. Silva-Sieger
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Acta Medica Colombiana uses the CC-BY 4.0 license. Authors retain all rights over their work.